既往杂交主动脉弓修复患者中分支型主动脉弓腔内修复装置及球囊扩张桥接支架的解剖适用性
本研究为单中心回顾性临床前适用性研究,分析1999至2022年间外科手术患者的术前CT,评估两种三分支主动脉弓装置(aBranch,Terumo Aortic与Cook Medical)及球囊扩张覆膜支架(VBX)在既往杂交胸主动脉腔内修复(TEVAR)患者中纳入头臂干(BCT)的解剖适用性。择期患者(n=73)中任一aBranch适用率为82.2%(60/73),VBX在BCT中适用率为64.4%(47/73);全队列aBranch总体适用率为82.9%,忽略次要IFU标准后升至86.3%,VBX在BCT中解剖适用率为73.2%。作者认为aBranch装置在绝大多数(86%)杂交TEVAR患者中解剖适用,头臂干似乎可在近三分之二患者中纳入VBX。
要点
- 择期患者中任一aBranch解剖适用率为82.2%(60/73),VBX在BCT中适用率为64.4%(47/73)。
- Terumo Aortic与Cook Medical装置适用率分别为52.1%(38/73)和46.6%(34/73)。
- 忽略次要IFU标准后,全队列aBranch适用率由82.9%升至86.3%。
核心结论
- aBranch装置在绝大多数(86%)接受杂交TEVAR的患者中解剖适用。
- 头臂干似乎在近三分之二患者中适合纳入VBX。
- 该桥接支架可能有助于克服部分次要IFU限制。
研究设计与样本
- 单中心、回顾性、全纳入、临床前适用性研究,分析1999至2022年间单一血管外科单元外科手术患者的术前CT扫描。
- 研究期间共治疗120例患者;择期患者73例。
- 主要结局为既往杂交TEVAR中aBranch装置及VBX作为BCT桥接支架的主动脉适用性。
主要发现
- 择期患者(n=73)中任一aBranch适用率为82.2%(60/73),VBX在BCT中适用率为64.4%(47/73)。
- aBranch适用患者较不适用患者窦管交界至BCT长度显著更长(P=.017),远端升主动脉显著更小(P=.043)。
- Terumo Aortic与Cook Medical装置适用率分别为52.1%(38/73)和46.6%(34/73);忽略次要IFU标准后分别增至82.2%(60/73)和63.0%(46/73)。
- 多变量分析中,左颈总动脉直径和窦管交界至BCT长度为Terumo Aortic aBranch不适用显著危险因素;Cook Medical装置未发现关联。
- 全队列测试显示aBranch总体适用率为82.9%,忽略次要IFU后增至86.3%;VBX在患者BCT中解剖适用率为73.2%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed the suitability of two triple branch arch devices (aBranch) (Terumo aortic and Cook Medical) and a balloon-expandable covered stent (VBX, W. L. Gore & Associates, Johnson & Johnson) to incorporate the brachiocephalic trunk (BCT) in a cohort previously treated with hybrid thoracic endovascular repair (TEVAR). METHODS: This is a single-center, retrospective, all-comers, preclinical suitability study. We conducted an analysis of preoperative computed tomography scans in surgical patients between 1999 and 2022 in a single vascular surgery unit. The primary outcome was the aortic suitability of aBranch devices and VBX as mating stent for BCT in previous hybrid TEVAR. Hybrid repair of the aortic arch included TEVAR, fenestrated or branched TEVAR associated with any surgical debranching of the supra-aortic trunks and chimney TEVAR with proximal landing in zones 0 to 2. Secondary outcomes included (i) suitability assessment when excluding minor instruction for use (IFU) criteria, (ii) a comparison of suitable and nonsuitable patients, (iii) risk factors analysis for nonsuitability, and (iv) a description of the exclusion causes. RESULTS: During the study period, 120 patients were treated. Among elective patients (n = 73), the suitability of any aBranch was 82.2% (60/73) and VBX was suitable in 64.4% of BCTs (47/73). The aBranch suitable patients had a significantly longer sinotubular-BCT length (P = .017) and smaller distal ascending aorta (P = .043) as compared with nonsuitable ones. The suitability of Terumo Aortic and Cook Medical devices was 52.1% (38/73) and 46.6% (34/73), respectively. When minor IFU criteria were ignored, suitability increased to 82.2% (60/73) and 63.0% (46/73), respectively. Left common carotid artery diameter and sinotubular-BCT length were significant nonsuitability risk factors for Terumo Aortic aBranch in multivariable analysis. No associations were found for Cook Medical device. The outcomes were tested in the entire cohort demonstrating a global suitability of 82.9%, increasing to 86.3% when ignoring minor IFUs. VBX was anatomically suitable to use in BCT in 73.2% of patient BCTs. CONCLUSIONS: aBranch devices are anatomically suitable in a vast majority of patients (86%) undergoing hybrid TEVAR. The innominate artery seems eligible for incorporation with VBX in almost two-thirds of patients. This mating stent may help to overcome some minor IFU restrictions.
引用
- Leone N, Bartolotti LAM, Baresi GF, et al. Anatomical suitability for branched endovascular aortic arch repair and balloon-expandable bridging stent grafts in a cohort of patients previously treated with a hybrid approach. J Vasc Surg. 2023. PMID: 37967588. doi:10.1016/j.jvs.2023.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。